On 10 November 2015, it was reported that prosecutors in the United States are planning to request that the Canadian and British governments extradite officials of the online pharmacy, CanadaDrugs.com, in connection with the alleged smuggling of $78 million worth of mislabelled, unapproved and counterfeit cancer drugs into the US to sell to doctors. The report is here.
According to the report, fourteen companies and individuals from Canada, the United Kingdom, and Barbados, and the US are accused of participating in the alleged conspiracy that involved falsifying customs declarations and shipments from the UK.
CanadaDrugs.com Ltd., the internet pharmacy based in Winnipeg, Canada, and its CEO, Kristjan Thorkelson, are accused of leading the conspiracy, aided by a subsidiary in the UK, River East Supplies Ltd., and two subsidiaries in Barbados, Rockley Ventures Ltd. and Global Drug Supply Ltd.
The medicines named in the criminal indictment are mainly drugs that treat cancer or the effects of chemotherapy. Nearly all of the drugs are legal in the US when sold by manufacturers and marketers approved by the Food and Drug Administration (FDA).
US officials will seek assistance through extradition treaties to detain Mr Thorkelson, other officers working for CanadaDrugs Ltd., and their representatives in the UK, Assistant U.S. Attorney Chad Spraker stated in a court filing.
“The United States anticipates that service through the foreign governments will take place before the proposed initial appearance date during the week of January 11, 2016,” Mr Spraker stated.